- 1 Benzyl Alcohol Info Emerald.PDF
- 1 Eligard Composition Atrigel 1-6 Months.pdf
- 1 Lactel PLGA IV-MW.pdf
- 1 Polyethylene glycol, The MAK Collection 2002.pdf
- 1 RESOMER-products, Evonik.pdf
- Alkilany 2019, Facile Functionalization of gold nanoparticles with PLGA polymer brushes and efficient encapsulation into PLGA nanoparticles.pdf
- Allison 2008, Effect of structural relaxation of PLGAS microparticles.pdf
- Alsadat 2018, Fabrication and in vitro evaluation of magnetic PLGA nanoparticles.pdf
- Andhariya 2017, Accelerated in vitro release testing method for naltrexone loadedP LGA microspheres.pdf
- Avgoustakis 2005, PLGA.pdf
- Ayoub 2018, Injectable PLGA adefovir microspheres.pdf
- Azimin 2014, Poly(latide-co-glycolide) fiber. An overview.pdf
- Basu 2018, Fabrication of core-shell PLGAPLA-pNIPAM nanocomposites.pdf
- Bile 2015, Parameters influencing the morphology of PCL and the resulting release of encapsulated drugs.pdf
- Bragagni 2018, Improving the therapeutic efficacy of prilocaine by PLGA microparticles.pdf
- Brown 2008, Solventnon-solvent sintering- A novel route to create porous microsphere scaffolds for tissue regeneration.pdf
- Burgess 1985, Manufacture of gelatingelatin coacervate microcapsules.pdf
- Busato 2018, Effect of particle size, polydispersity and polymer degradation on progesteron release from PLGA.pdf
- Castro-Aguirre 2016, Poly(lactic acid) - Mass production, processing, industrial applications, and end of life.pdf
- Chang 2015, Investigation of fragment antibody stability and its release mechanism from PLGA–triacetin depots for sustained-release applications.pdf
- Charlie-Silva 2018, Nanoparticle mucoadhesive system as a new tool for fish immune system modulation.pdf
- Chen 2018, Anhydrous reverse micelle lecithin nanoparticles-PLGA composite microspheres for protein delivery.pdf
- Chen 2018, Facile fabrication of bowl-shaped micriparticles.pdf
- Chen 2018, Tunable degradation of acetalated dextran micoparticles enables controlled vaccine adjuvant and antigen delivery.pdf
- Chereddy 2016, PLGA based drug delivery systems.pdf
- Controlled crystalization 2012, US20120213827A1.pdf
- CriticalMix Injectable Sustained Release Technology 2017.pdf
- d'Arcy 2016, Branched polyesters- Preparative strategies and applications.pdf
- Dastida 2018, Porous microspheres- Synthesis characterzation and applications.pdf
- Dastidar 2018, Porous microspheres- Synthesis, characterisation and applications in pharmaceutical & medical fields.pdf
- Davvodi 2018, Drug delivery systems for programmed and on-demand release.pdf
- Ding 2018, PLGA for biomoecular therapeutiocs.pdf
- dos Santos 2018, Vasorelaxant effect of standardized extract of Cecropia glaziovii sneth1.pdf
- Eilleia 2018, Novel technoque of insulin loading into porous carriers for oral delivery.pdf
- Friess 2002, Release mechanisms from gentamicin loaded PLGA microparticles.pdf
- Gasparini 2008, Preparation and characterization of PLGA particles.pdf
- Gomeni 2013, RBP-7000, a new, long-acting sustained-release formulation of risperidone.pdf
- Goodfriend 2016, Thermally processed polymeric microparticles for year-long delivery of dexamethasone.pdf
- Graves 2007, Buprenorphine in situ gel formulation.pdf
- Grizic 2018, Microparticle preparation by a propylene carbonate emulsification.pdf
- Guarecuco 2018, Immunogenicity of pulsatile-release PLGA microspheres.pdf
- Guo 2015, Sustained release donepezil loaded PLGA microspheres for injection.pdf
- Guo 2018, Three-dimensional PLGA-silica collidal crystal microparticles.pdf
- Hajavi 2018, Optimization of PLGA formiulation containing protein or peptide.pdf
- Hasan 2015, Reduction of the in vivo burst release of insulin-loaded microparticles.pdf
- Heidariyan 2018, Efficient and cost-effective generation of hepatocyte-like cells.pdf
- Hirota 2016, Characterizing release mechanisms of leuprolide acetate-loaded PLGA microspheres for IVIVC development I- In vitro evaluation.pdf
- Houchin_2008, Chemical degradation of peptides and proteins in PLGA.pdf
- Huang 2018, Tuning the size of PLGA nanoparticles.pdf
- Isitt 2016, RBP-7000 once monthly risperidone- An 8-week phase 3 study.pdf
- Jain 2016, Injectable formulations of poly(lactic acid) and its copolymers in clinical use.pdf
- Jang 2018, Ultrasound-trigeered PLGA microparticle destruction and degradation.pdf
- Ji 2016, Drug release kinetics and mechanism from PLGA formulations.pdf
- Kamali 2018, An in-situ forming implant formulation of naltrexone with minimum initial burst release.pdf
- Keles 2015, Investigation of factors influencing the hydrolytic degradation of single PLGA microparticles.pdf
- Kharel 2018, Hollow microparticles as a superior delivery system over solid microparticles for the encapsulation of peptides.pdf
- Kim 2016, Three-dimensional, high-porosity conducting skeletal structure from biodegradable microparticles with vapor-phase polymerized conformal surface layer.pdf
- Klose 2011, Unintended potential impact of perfect sink conditions on PLGA degradation.pdf
- Koenig 2003, A review of polymer dissolution.pdf
- Laffont 2014, Population Pharmacokinetics after multiple doses of RBP-7000.pdf
- Laffont 2015, Dose selection for RBP-7000, a new sustained-release formulation of risperidone.pdf
- Lassalle 2010, PLGA based drug delivery systems(DDS) for the sustained release of insulin.pdf
- Lee 2018, Poly(lactic-co-glycolic acid) devices- Production and applications for sustained protein delivery..docx
- Lee 2018, Poly(lactic-co-glycolic acid) devices- Production and applications for sustained protein delivery.pdf
- Li 1995, Prediction of solvent removal profile and effect on properties for peptide-loaded PLGA microspheres.pdf
- Li 2005, Mapping neutral microclimate pH in PLGA microspheres.pdf
- Li 2018, Preparation of PLGA microspheres and evaluation of PK in rats.pdf
- Liao 2016, Size matters Effets of PGLA-microsphere size.pdf
- Lin 2018, Exenatide-loaded PLGA microspheres.pdf
- Liu 2012, Cosolvent effects on the drug release and depot swelling in injectable in situ depot.pdf
- Liu 2019, Manufacture of solvent-free polylactic-glycolic acid (PLGA) scaffolds for tissue engineering.pdf
- Malik 2010, Atrigel- A potential parenteral controlled drug delivery system.pdf
- Martín-Sabroso 2015, Critical attributes of formulation and of elaboration process of PLGA-protein microparticles.pdf
- Martín-Sabroso 2015, Critical attributes of PLGA-protein microparticles.pdf
- McClements 2018, Encapsulation, protection, and delivery of bioactive proteins and peotides.pdf
- Miller 2006, PLGA nanometer surface features manipulate fibronectin interactions for improved vascular cell adhesion.pdf
- Mohammad 2013, Quantitative detection of PLGA nanoparticle degradation in tissues following intravenous administration.pdf
- Mohanty 2003, Systematic of alcohol-induced simple coacervation in aqueous gelatin solutions.pdf
- Mohanty 2005, Synthesis of Gelatin Nanoparticles via_ imple Coac.pdf
- Murariu 2016, PLA composites- From production to properties.pdf
- Mylonaki 2018, Imaging the porous structure in the core of degrading PLGA microparticles.pdf
- Mylonaki 2018, Imaging the porous structure in the core of degrading PLGA MPs.pdf
- Nanaki 2017, Use of mesoporous cellular foam (MCF).pdf
- Nasser 2014, RBP-6000, a new long-acting, sustained-release formulation of buprenorphine.pdf
- Nieto 2018, In vivo controlled release of fenretinide from long-acting release depots.pdf
- Nii 2018, Effects of the conformation of PLGA molecules in the organic solvents.pdf
- Nomura 2018, Benign preparation of aqueous core PLGA microcapsules.pdf
- Ogaki 2008, Extracting information on the surface monomer unit distribution of PLGAb y ToF-SIMS.pdf
- Ong 2018, Production of drug-releasing biodegradable microporous scafold.pdf
- Palmer 2017, Printing particles- A high throughput technique.pdf
- Parent 2013, PLGA in situ implants formed by phase inverstion.pdf
- Perron 2009, A study on the effect of degradation media on the physical and mechanical properties of porous PLGA 8515 scaffolds.pdf
- Perseris Indivior.pdf
- Phaechamud 2016, Pore formation mechanism of porous poly(DL-lactic acid) matrix membrane.pdf
- Pisal 2010, Delivery of therapeutic proteins.pdf
- PLGA nanoparticles- Particle size and drug encapsulation efficiency.pdf
- Ponnusamy 2014, Novel “breath figure”-based synthetic PLGA matrices for in vitro modeling.pdf
- Powers 2012, Determining the polydispersity in chemical composition and monomer sequence distribution in random copolymers prepared.pdf
- Qutachi 2018, Improved delivery of PLGA microparticles.pdf
- Ratzinger 2010, Mechanistic studies on the self-assembly of PLGA patchy particles and their potential applications in biomedical imaging.pdf
- Rege 2018, Structure-based stabilization of insulin as a therapeutic protein assembly via enhanced aromatic-aromatic interactions.pdf
- Rocha-Selmi 2013, Microencapsulation of aspartame by double emulsion followed by complex coacervation.pdf
- Rothe 2018, Dose equivalent for second generation long-acting injectable antipsychotics.pdf
- Saez 2016, Quantification of oxaliplatin encapsulated into PLGA microspheres by TGA.pdf
- Sah 1997, Microencapsulation techniques using ethyl acetate as a dispersed solvent- effects of its extraction rate.pdf
- Saini 2016, Poly(lacticacid) blends in biomedical applications.pdf
- Sander 2003, Solvent effect on the microstructure and properties of 7525 PLGA tissue scaffolds.pdf
- Savador-Morales 2016, Mechanistic studies on the self-assembly of PLGA patchy particles and their potential applications in biomedical imaging.pdf
- Schwendeman 2014, Injectable controlled release depots for large molecules.pdf
- Semler 2007, Facile method of controlling monomer sequence distributions in random copolymers.pdf
- Sequeira 2018, PLGA matrix implants.pdf
- Shi 2002, Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres.pdf
- Shi 2017, Polymer phase separation in a microcapsule shell.pdf
- Siepman 2005, How autocatalysis accelerates drug release from PLGA-based microparticles- A quantitative treatment.pdf
- Siggia 1979, Late stages of spinodal decomposition in binary mixtures.pdf
- Soliman 2018, A narrative review of the success of intramuscular gluteal injections.pdf
- Solubility of homopolymers.pdf
- Solvents- Theory and applications 2013.pdf
- Song 2018, Porous PLGA-PCL bilayer membrane.pdf
- Steele 2011, High-throughput screening of PLGA thin films utilizing hydrophobic fluorescent dyes for hydrophobic drug compounds.pdf
- Steinman 2019, Effect of PLGA block molecular weight on gelling temperature of plga-peg-plga thermoresponsive copolymers.pdf
- Sun 2014, Laser-activatible PLGA microparticles for image-guided cancer therapy in vivo.pdf
- Sun 2017, Phase separation of in situ forming PLGA implants.pdf
- Swider 2018, Customizing PLGA particles for biomedical applications.pdf
- Tadros 2013, Emulsion formation, stability, and rheology.pdf
- Tamani 2019, Towards a better understanding of the release mechanisms of caffeine from PLGA microparticles.pdf
- Teekamp 2017, Polymeric microspheres for the sustained release of a protein-based drug.pdf
- Thies, Microcapsules.pdf
- Thomasin 1998, Drug microencapsulation bu PLA-PLGA coacervation in the light of thermodynamics.pdf
- Tomic 2016, Setting accelerated dissolution test for PLGA microspheres containing peptide, investigation of critical parameters.pdf
- Tomic 2018, In vivo release of peptide-loaded PLGA assessed through deconvolution.pdf
- Tsujimoto 2018, PLGA nanoparticle design and preparation for DDS and medical devie.pdf
- Turek 2015, Thermal properties and morphology changes in degradation process of PLGA matrices with risperidone.pdf
- Turek 2018, Formulation of delivery systems with risperidone based on biodegradable terpolymers.pdf
- US20140243278A1 Acid addition salt of donepezil.pdf
- US20160022583A1.lnk
- van Apeldoom 2004, Raman imaging of PLGA microparticle degradation insiude macrophages.pdf
- Vladisavljevic 2015, Structured microparticles with tailored properties produced by membrane emulsification.pdf
- Vora 2017, Zero order controlled release of cholecalciferol from injectable PLGA microsphere.pdf
- Wan 2016m PLGA-baseed depot delivery systems for biopharmaceuticals.pdf
- Wang 2002, Characterization of the initial burst release of a model peptide from poly(D.L-lactide-co-glycolide) microspheres.pdf
- Wang 2018, Azithromycin-loaded respirable microspheres for targeted pulmonary delivery.pdf
- Wang 2018, Lipid-coated mannitol core microparticles for sustained release of protein.pdf
- Washington 2018, Monomer sequence in PLGA microparticles.pdf
- Weerachanchai 2014, Determination of solubility parameters from intrinsic viscosity.pdf
- Wong-Moon 2008, NMR spectroscopic evaluation of the internal environment of PLGA microspheres.pdf
- Wong 2018, Microparticles, microcapsules and microspheres.pdf
- Wu 2018, Lipid and PLGA hybrid microparticles as carriers for protein delivery.pdf
- Wu 2018, Lipid and PLGA hybrid microparticles for proitein delivery.pdf
- Xin 2018, Bi-multi-modal pore formation of PLGA-hydroxyapatite composite scaffolds.pdf
- Xu 2016, Polymer degradation and drug delivery in PLGA-based drug–polymer Applications- A review of experiments and theories.pdf
- Xu 2017,. Polymer degradation and drug delivery in PLGA‐based drug–polymer applications.pdf
- Yoshimoto 2018, Layered PLGA membranes.pdf
- Yu 2011, Influence of LA and GA sequence in the PLGA block on the properties of thermogelling PLGA-PEG-PLGA block copolymers.pdf
- Zerrillo 2019, pH-responsive PLGA nanoparticles containing near-infrared dye for visualization and hyaluronic acid for treatment ofosteoarthritis.pdf
- Zhang 2007, In vitro and in vivo evaluation of donepezil-sustained release microparticles for the treatment of Alzheimer's disease.pdf
- Zhang 2016, Design of controlled release PLGA microspheres for hydrophobic fenretinide.pdf
- Zhang 2017, Absolute quantification of PLGA by 1H NMR.pdf
- Zhu 2018, PLGA spherical nucleic acids.pdf
